Moisand Fitzgerald Tamayo, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Moisand Fitzgerald Tamayo, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	SELL	$28.0 - $40.56 $952 - $1,379	-34 Reduced 87.18%	5 $0
Q3 2022 Oct 26, 2022	SELL	$29.63 - $48.31 $948 - $1,545	-32 Reduced 45.07%	39 $1,000
Q2 2022 Aug 01, 2022	BUY	$27.79 - $50.61 $194 - $354	7 Added 10.94%	71 $2,000
Q1 2022 Apr 29, 2022	BUY	$39.62 - $69.97 $2,337 - $4,128	59 Added 1180.0%	64 $3,000
Q4 2020 Feb 02, 2021	BUY	$43.82 - $85.37 $219 - $426	5 New	5 $0

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Moisand Fitzgerald Tamayo, LLC, based on Form 13F filings with the SEC.

Stay updated on Moisand Fitzgerald Tamayo, LLC with notifications on news.